相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dioscin: A review on pharmacological properties and therapeutic values
Shinjini Bandopadhyay et al.
BIOFACTORS (2022)
Neoechinulins: Molecular, cellular, and functional attributes as promising therapeutics against cancer and other human diseases
Sicon Mitra et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives-A review
Uttpal Anand et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
Sicon Mitra et al.
FRONTIERS IN PHARMACOLOGY (2022)
Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective
Uttpal Anand et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2022)
Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
Ligong Lu et al.
HEPATOLOGY (2021)
How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
Lu Cao et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects
Subhabrata Paul et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
Ali R. Jazirehi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents
Wenzhong Yan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das et al.
DRUG RESISTANCE UPDATES (2021)
Targeting adenosine and regulatory T cells in cancer immunotherapy
Alexey Churov et al.
HUMAN IMMUNOLOGY (2021)
Immune checkpoint inhibitors
Guido Kroemer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Advancing oncolytic virus therapy by understanding the biology
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The Chemistry of Nonclassical Taxane Diterpene
Fabian Schneider et al.
ACCOUNTS OF CHEMICAL RESEARCH (2021)
Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
Kawaljeet Kaur et al.
FRONTIERS IN MICROBIOLOGY (2021)
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Varda Shoshan-Barmatz et al.
FRONTIERS IN PHYSIOLOGY (2021)
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
Rafael Franco et al.
CELLS (2021)
Antimicrobial peptides against colorectal cancer-a focused review
Sonia Chauhan et al.
PHARMACOLOGICAL RESEARCH (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Iris Lodewijk et al.
CLINICAL EPIGENETICS (2021)
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
Pier Francesco Ferrucci et al.
CANCERS (2021)
Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate
Ross J. Porter et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
TCR gene-engineered cell therapy for solid tumors
Elaine Tan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2021)
Adenosine and Inflammation: Here, There and Everywhere
Silvia Pasquini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
Shivika Datta et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens
Tushar Khare et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
Saikat Dewanjee et al.
CELLS (2021)
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
Guoqiang Sun et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Advancing urban ethnopharmacology: a modern concept of sustainability, conservation and cross-cultural adaptations ofmedicinal plant lore in the urban environment
Tusheema Dutta et al.
CONSERVATION PHYSIOLOGY (2021)
Revisiting the hallmarks of cancer: The role of hyaluronan
Ilaria Caon et al.
SEMINARS IN CANCER BIOLOGY (2020)
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
Shian-Ren Lin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Clinical Applications of Antimicrobial Peptides (AMPs): Where do We Stand Now?
Mithoor Divyashree et al.
PROTEIN AND PEPTIDE LETTERS (2020)
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Peter Kreuzaler et al.
MOLECULAR METABOLISM (2020)
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jaeger et al.
BLOOD REVIEWS (2020)
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
Zhida Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Atezolizumab for the treatment of breast cancer
Sangeetha M. Reddy et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Merry Jennifer Markham et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
CAR T cells: continuation in a revolution of immunotherapy
Anurag K Singh et al.
LANCET ONCOLOGY (2020)
How autophagy can restore proteostasis defects in multiple diseases?
Vibhuti Joshi et al.
MEDICINAL RESEARCH REVIEWS (2020)
Metabolic Cycles in Cancer Cells?
Andrew Moore
BIOESSAYS (2020)
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy
Jie Zhao et al.
CANCER LETTERS (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
Connie Kang et al.
DRUGS (2020)
Atezolizumab in the treatment of metastatic triple-negative breast cancer
Jose Perez-Garcia et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
Amr Omar et al.
SCIENTIFIC REPORTS (2020)
Circulating Tumor DNA Testing-Liquid Biopsy of a Cancer
Kyrillus S. Shohdy et al.
JAMA ONCOLOGY (2020)
Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death
Jinghong Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Rethinking the adenosine-A2AR checkpoint: implications for enhancing anti-tumor immunotherapy
Rachel S. Helms et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Xingyi Pan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
Fazhi Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
Panagiotis A. Konstantinopoulos et al.
LANCET ONCOLOGY (2020)
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
Anna Lucia Tornesello et al.
MOLECULES (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Carboplatin plus etoposide or topotecan for small-cell lung cancer
Oscar Arrieta et al.
LANCET ONCOLOGY (2020)
Human cathelicidin antimicrobial peptide suppresses proliferation, migration and invasion of oral carcinoma HSC-3 cells via a novel mechanism involving caspase-3 mediated apoptosis
Xi Chen et al.
MOLECULAR MEDICINE REPORTS (2020)
Emerging connectivity of programmed cell death pathways and its physiological implications
Sammy Bedoui et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
Deep learning technology for improving cancer care in society: New directions in cancer imaging driven by artificial intelligence
Mario Coccia
TECHNOLOGY IN SOCIETY (2020)
ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
S. M. Gilbert et al.
ONCOGENE (2019)
Principles of adoptive T cell therapy in cancer
Ozcan Met et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
Maria Valeria Raimondi et al.
MOLECULES (2019)
From Antimicrobial to Anticancer Peptides: The Transformation of Peptides
Yuan Qin et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
High content screening identifies monensin as an EMT-selective cytotoxic compound
Marion Vanneste et al.
SCIENTIFIC REPORTS (2019)
Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism
Jiani Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Recent advances in triple negative breast cancer: the immunotherapy era
Antonio Marra et al.
BMC MEDICINE (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: roles of depolymerizing kinesins and severing proteins
Jessica C. Leung et al.
CANCER BIOLOGY & THERAPY (2019)
Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches
Daniela Rodrigues et al.
CANCER TREATMENT REVIEWS (2019)
Progress in research on paclitaxel and tumor immunotherapy
Linyan Zhu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
New insight into NANOG: A novel therapeutic target for ovarian cancer (OC)
Iyer Mahalaxmi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Daniela Matei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94
Francesca Caccuri et al.
CANCERS (2019)
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan et al.
CANCER RESEARCH (2019)
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Chloe Laplagne et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Highlights in Resistance Mechanism Pathways for Combination Therapy
Joao M. A. Delou et al.
CELLS (2019)
Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy
Urs Giger-Pabst et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser et al.
CANCER CELL (2019)
Cancer Nanomedicine: A New Era of Successful Targeted Therapy
Mahmoud Zaki El-Readi et al.
JOURNAL OF NANOMATERIALS (2019)
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
Prakirthi Yerram et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Irinotecan: 25 years of cancer treatment
Christian Bailly
PHARMACOLOGICAL RESEARCH (2019)
2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
Anupama Chaudhary et al.
SCIENTIFIC REPORTS (2019)
Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
Tala M. Abu Samaan et al.
BIOMOLECULES (2019)
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
Uttpal Anand et al.
METABOLITES (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
Safety and Tolerability of Adoptive Cell Therapy in Cancer
Benita Wolf et al.
DRUG SAFETY (2019)
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
Olga M. Kutova et al.
CANCERS (2019)
Antimicrobial peptides: new hope in the war against multidrug resistance
James Mwangi et al.
ZOOLOGICAL RESEARCH (2019)
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
Tomaz Makovec
RADIOLOGY AND ONCOLOGY (2019)
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Isaac Kim et al.
CURRENT BREAST CANCER REPORTS (2019)
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery
Danielle E. Large et al.
ADVANCED THERAPEUTICS (2019)
Unexpected therapeutic effects of cisplatin
Martina Raudenska et al.
METALLOMICS (2019)
Advances in nano-delivery systems for doxorubicin: an updated insight
Ummarah Kanwal et al.
JOURNAL OF DRUG TARGETING (2018)
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Emanuela Martino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues
Ashanul Haque et al.
CURRENT MEDICINAL CHEMISTRY (2018)
The evolving role of DNA inter-strand crosslinks in chemotherapy
Halley B. Rycenga et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer
Martin Reck
IMMUNOTHERAPY (2018)
Vinorelbine's anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas
Meric A. Altinoz et al.
JOURNAL OF CHEMOTHERAPY (2018)
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features
Tsetan Dolkar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Proteasome-mediated proteostasis: Novel medicinal and pharmacological strategies for diseases
Ribhav Mishra et al.
MEDICINAL RESEARCH REVIEWS (2018)
Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
Lorena Infante Lara et al.
NUCLEIC ACIDS RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Tumor suppressor activity of miR-451: Identification of CARF as a new target
Ling Li et al.
SCIENTIFIC REPORTS (2018)
Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges
Lubhandwa S. Biswaro et al.
FRONTIERS IN MICROBIOLOGY (2018)
From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
Guido Gambara et al.
FRONTIERS IN PHARMACOLOGY (2018)
CARF enrichment promotes epithelial-mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target
Rajkumar S. Kalra et al.
ONCOGENESIS (2018)
Innovative Technologies Changing Cancer Treatment
Sara Charmsaz et al.
CANCERS (2018)
Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells
Sara Sannino et al.
JOURNAL OF CELL SCIENCE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review
Bashar Emon et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Hannah A. Blair
DRUGS (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Anna Lichota et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer
Hui Sun et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?
Jean Jacques Grob et al.
LANCET ONCOLOGY (2018)
Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules
Yiming Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone et al.
FRONTIERS IN PHARMACOLOGY (2018)
Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction
Emanuele Bruni et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cathelicidins: Immunomodulatory Antimicrobials
Roel M. van Harten et al.
VACCINES (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Shigeo Horie et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
Darcy Bates et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Systematic review of ixabepilone for treating metastatic breast cancer
Jing Li et al.
BREAST CANCER (2017)
Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
Tracy Murphy et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules
Butch KuKanich et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2017)
Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study
Kiyoshi Hasegawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
2,3-Dihydro-3β-methoxy Withaferin-A Protects Normal Cells against Stress: Molecular Evidence of Its Potent Cytoprotective Activity
Anupama Chaudhary et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee et al.
LANCET ONCOLOGY (2017)
CARF is a multi-module regulator of cell proliferation and a molecular bridge between cellular senescence and carcinogenesis
Renu Wadhwa et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2017)
Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms
Zeina Habli et al.
MOLECULES (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antimicrobial peptides: Role in human disease and potential as immunotherapies
Cesar de la Fuente-Nunez et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis
Ethan L. Matz et al.
UROLOGY (2017)
Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview
Raheleh Roudi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism
Balaraman Kalyanaraman
REDOX BIOLOGY (2017)
Peptides with Dual Antimicrobial and Anticancer Activities
Mario R. Felicio et al.
FRONTIERS IN CHEMISTRY (2017)
Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
Michelle C. Salazar et al.
JAMA ONCOLOGY (2017)
The immune system in cancer metastasis: friend or foe?
Louise M. E. Janssen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Adult T-Cell Leukemia/Lymphoma
Neha Mehta-Shah et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Amy Barone et al.
CLINICAL CANCER RESEARCH (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Molecular features that predict the response to antimetabolite chemotherapies
Mahya Mehrmohamadi et al.
CANCER & METABOLISM (2017)
A systematic analysis of FDA-approved anticancer drugs
Jingchun Sun et al.
BMC SYSTEMS BIOLOGY (2017)
Advances and challenges in targeting FGFR signalling in cancer
Irina S. Babina et al.
NATURE REVIEWS CANCER (2017)
Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine's Drug Conjugates on Cancer Therapy
Sathish Dyawanapelly et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2017)
The long story of camptothecin: From traditional medicine to drugs
Emanuela Martino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
The Principles of Engineering Immune Cells to Treat Cancer
Wendell A. Lim et al.
CELL (2017)
Doxorubicin: nanotechnological overviews from bench to bedside
Maximiliano Cagel et al.
DRUG DISCOVERY TODAY (2017)
High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma
Doh Yu Hwang et al.
LEUKEMIA & LYMPHOMA (2016)
Ibuprofen Induces Mitochondrial-Mediated Apoptosis Through Proteasomal Dysfunction
Arun Upadhyay et al.
MOLECULAR NEUROBIOLOGY (2016)
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Jeanne Palmer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Stress Chaperone Mortalin Contributes to Epithelial-to-Mesenchymal Transition and Cancer Metastasis
Youjin Na et al.
CANCER RESEARCH (2016)
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Gwo Yaw Ho et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review
Zhiqiang Yu et al.
CURRENT CANCER DRUG TARGETS (2016)
The immune system
Lindsay B. Nicholson
UNDERSTANDING BIOCHEMISTRY 2 (2016)
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
Delisha A. Stewart et al.
JOURNAL OF PROTEOME RESEARCH (2016)
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
Adam Fabisiak et al.
PHARMACOLOGICAL REPORTS (2016)
Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
Paul E. Hughes et al.
TRENDS IN IMMUNOLOGY (2016)
Epigenetic control of the tumor microenvironment
David L. Marks et al.
EPIGENOMICS (2016)
Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
K. Begna et al.
BLOOD CANCER JOURNAL (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
Rachel M. McQuade et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cancer nanomedicine: is targeting our target?
Twan Lammers et al.
NATURE REVIEWS MATERIALS (2016)
Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer
Kiran Annam et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
L. Apetoh et al.
ANNALS OF ONCOLOGY (2015)
Clinical Next Generation Sequencing for Precision Medicine in Cancer
Ling Dong et al.
CURRENT GENOMICS (2015)
Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Chun-Ting Lee et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
Katarzyna Niemirowicz et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Novel delivery approaches for cancer therapeutics
Ashim K. Mitra et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
CARF (Collaborator of ARF) overexpression in p53-deficient cells promotes carcinogenesis
Rajkumar S. Kalra et al.
MOLECULAR ONCOLOGY (2015)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
Zainul S. Hasanali et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
Daniele Fanale et al.
ANALYTICAL CELLULAR PATHOLOGY (2015)
Human Tumor Antigens and Cancer Immunotherapy
Nathalie Vigneron
BIOMED RESEARCH INTERNATIONAL (2015)
Cancer: We Should Not Forget The Past
Anna Di Lonardo et al.
JOURNAL OF CANCER (2015)
Beyond BRAF: where next for melanoma therapy?
I. V. Fedorenko et al.
BRITISH JOURNAL OF CANCER (2015)
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman et al.
NATURE REVIEWS CANCER (2015)
Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy
Raju Vivek et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Taxanes: their impact on gynecologic malignancy
Carlton L. Schwab et al.
ANTI-CANCER DRUGS (2014)
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series
Joshua D. Rosenberg et al.
BLOOD (2014)
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
M. D'Incalci et al.
BRITISH JOURNAL OF CANCER (2014)
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2014)
Capecitabine Plus Irinotecan Versus 5-FU/Leucovorin Plus Irinotecan in the Treatment of Colorectal Cancer: A Meta-analysis
Yuanbiao Guo et al.
CLINICAL COLORECTAL CANCER (2014)
Sexual dysfunction and infertility as late effects of cancer treatment
Leslie R. Schover et al.
EJC SUPPLEMENTS (2014)
Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies
Rabih Said et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
New advances in the treatment of atrial fibrillation: focus on stroke prevention
Yee C. Lau et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma
Madzouka B. Kokolo et al.
LEUKEMIA & LYMPHOMA (2014)
Cancer-related fatigue-mechanisms, risk factors, and treatments
Julienne E. Bower
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy
Pashna N. Munshi et al.
ONCOLOGIST (2014)
Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens
Chidozie C. Anyaegbu et al.
PLOS ONE (2014)
Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
Guan Jiang et al.
PLOS ONE (2014)
The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
Ana Costa et al.
SEMINARS IN CANCER BIOLOGY (2014)
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
N. Hasima et al.
CELL DEATH & DISEASE (2014)
Raltitrexed-based chemotherapy for advanced colorectal cancer
Y. Liu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Vaccines for Cancer Prevention: A Practical and Feasible Approach to the Cancer Epidemic
Olivera J. Finn
CANCER IMMUNOLOGY RESEARCH (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
Samira Sadat Abolmaali et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)
Meng-Tao Ma et al.
CANCER LETTERS (2013)
Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
Denis Selimovic et al.
CELLULAR SIGNALLING (2013)
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
S. Mahner et al.
EUROPEAN JOURNAL OF CANCER (2013)
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
Aman U. Buzdar et al.
LANCET ONCOLOGY (2013)
Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
Elodie Moysan et al.
MOLECULAR PHARMACEUTICS (2013)
Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous system
Daniel Thorpe et al.
NEUROTOXICOLOGY (2013)
Expression Proteomics Predicts Loss of RXR-γ during Progression of Epithelial Ovarian Cancer
Rajkumar S. Kalra et al.
PLOS ONE (2013)
Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
Francesco Torino et al.
THYROID (2013)
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
Maria Vittoria Dieci et al.
CANCER DISCOVERY (2013)
Enhanced levels of double-strand DNA break repair proteins protect ovarian cancer cells against genotoxic stress-induced apoptosis
Rajkumar Singh Kalra et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
Metin Karahoca et al.
CLINICAL EPIGENETICS (2013)
Immune responses to cancer: are they potential biomarkers of prognosis?
Theresa L. Whiteside
FRONTIERS IN ONCOLOGY (2013)
Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy
Y. Maor et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2013)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G. Curigliano et al.
ANNALS OF ONCOLOGY (2012)
Antibody-Based Immunotherapy of Cancer
Louis M. Weiner et al.
CELL (2012)
Oxaliplatin: a review of approved uses
Alexander Stein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Hydroxyurea: a key player in cancer chemotherapy
Kapish Madaan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Targeted drug delivery for cancer therapy: the other side of antibodies
Michael A. Firer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Total Synthesis of Camptothecin and SN-38
Shanbao Yu et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives
George Mattheolabakis et al.
NANOMEDICINE (2012)
Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
Serkan Sertel et al.
PLOS ONE (2012)
Streptozocin-based chemotherapy is not history in neuroendocrine tumours
Katie Weatherstone et al.
TARGETED ONCOLOGY (2012)
Using antimicrobial adjuvant therapy in cancer treatment: a review
Kenneth Alibek et al.
INFECTIOUS AGENTS AND CANCER (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study
T. Mitchell et al.
EUROPEAN JOURNAL OF CANCER CARE (2011)
Chemotherapy, neurotoxicity, and cognitive changes in breast cancer
Varsha Dutta
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2011)
HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells
J. I-Ju Leu et al.
MOLECULAR CANCER RESEARCH (2011)
Cytarabine Dose for Acute Myeloid Leukemia
Bob Löwenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
US Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia
Sandra J. Casak et al.
ONCOLOGIST (2011)
The European Medicines Agency Review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the Treatment of Advanced Gastric Cancer When Given in Combination with Cisplatin: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use (CHMP)
Petra Matt et al.
ONCOLOGIST (2011)
LC-MS/MS Coupled with Stable Isotope Dilution Method for the Quantification of 6-Thioguanine and S6-Methylthioguanine in Genomic DNA of Human Cancer Cells Treated with 6-Thioguanine
Hongxia Wang et al.
ANALYTICAL CHEMISTRY (2010)
Arsenic trioxide - An old drug rediscovered
Ashkan Emadi et al.
BLOOD REVIEWS (2010)
Gene Expression: Protein Interaction Systems Network Modeling Identifies Transformation-Associated Molecules and Pathways in Ovarian Cancer
Sharmila A. Bapat et al.
CANCER RESEARCH (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Antibody-drug conjugates: targeted drug delivery for cancer
Stephen C. Alley et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
Cancer Chemotherapy: An Annotated History
W. B. Morrison
JOURNAL OF VETERINARY INTERNAL MEDICINE (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
K. Zhu et al.
ONCOGENE (2010)
Hemorrhagic cystitis: A challenge to the urologist
R. Manikandan et al.
INDIAN JOURNAL OF UROLOGY (2010)
DNA Damage Induced by Alkylating Agents and Repair Pathways
Natsuko Kondo et al.
JOURNAL OF NUCLEIC ACIDS (2010)
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
Terence C. Chua et al.
ANNALS OF SURGERY (2009)
Mechanisms of anti-cancer action and pharmacology of clofarabine
Anna Zhenchuk et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
Kjeld Schmiegelow et al.
BLOOD (2009)
Irinotecan-induced mucositis is associated with changes in intestinal mucins
Andrea M. Stringer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Exploring DNA-Binding Proteins with In Vivo Chemical Cross-Linking and Mass Spectrometry
Haibo Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Natural compounds for cancer treatment and prevention
Stefania Nobili et al.
PHARMACOLOGICAL RESEARCH (2009)
Advances of Cancer Therapy by Nanotechnology
Xu Wang et al.
CANCER RESEARCH AND TREATMENT (2009)
Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells
William Ka Kei Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Hairy cell leukemia: Current concepts
Timothy Cannon et al.
CANCER INVESTIGATION (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Gemcitabine in the management of metastatic breast cancer: a systematic review
Susan Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
MGMT hypermethylation: A prognostic foe, a predictive friend
Filipe V. Jacinto et al.
DNA REPAIR (2007)
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
John R. Eckardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Discovery and development of clofarabine: a nucleoside analogue for treating cancer
Peter L. Bonate et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Approval summary: Nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma
Martin H. Cohen et al.
CLINICAL CANCER RESEARCH (2006)
Temozolomide: a milestone in neuro-oncology and beyond?
Nicole Mutter et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Formation and repair of interstrand cross-links in DNA
DM Noll et al.
CHEMICAL REVIEWS (2006)
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Yong Wang et al.
CURRENT CANCER THERAPY REVIEWS (2006)
Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival
MT Tomicic et al.
CANCER RESEARCH (2005)
Syntheses and biological activities of disaccharide daunorubicins
GS Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review
FK Engels et al.
BRITISH JOURNAL OF CANCER (2005)
Comparative in vitro properties and clinical pharmacokinetics of paclitaxel following the administration of Taxol® and Paxene®
CD Scripture et al.
CANCER BIOLOGY & THERAPY (2005)
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial
BG Haffty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
O Tournilhac et al.
BLOOD (2004)
Delayed haematological complications of mustard gas
M Ghanei
JOURNAL OF APPLIED TOXICOLOGY (2004)
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide
C Arndt et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Azathioprine: old drug, new actions
JS Maltzman et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999)
AS Moore et al.
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2002)
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development
JL Grem
INVESTIGATIONAL NEW DRUGS (2000)
分享论文
